Postnatal Steroids for Bronchopulmonary Dysplasia: Where Are We Now?

Journal of Pediatrics

Volumn 150, Issue 4, 2007, Pages 327-328

  Watterberg, Kristi L ^a  

^a UNIVERSITY OF NEW MEXICO SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DEXAMETHASONE; GLUCOCORTICOID; HYDROCORTISONE; PLACEBO;

BRAIN FUNCTION; CEREBRAL PALSY; CLINICAL TRIAL; DRUG DOSE ESCALATION; DRUG EFFECT; DRUG MEGADOSE; DRUG SAFETY; DRUG SCREENING; DRUG WITHDRAWAL; EDITORIAL; GROWTH DISORDER; HUMAN; HYPERGLYCEMIA; HYPERTROPHIC CARDIOMYOPATHY; LOGISTIC REGRESSION ANALYSIS; LOW DRUG DOSE; LUNG DYSPLASIA; MENINGITIS; NEONATOLOGY; NERVE CELL DIFFERENTIATION; OUTCOME ASSESSMENT; POSTNATAL CARE; PREMATURITY; PRIORITY JOURNAL; RISK ASSESSMENT; SPINAL CORD COMPRESSION; TREATMENT DURATION;

ADRENAL CORTEX HORMONES; BRONCHOPULMONARY DYSPLASIA; HUMANS; INFANT, NEWBORN; NEONATOLOGY; PRACTICE GUIDELINES; TREATMENT OUTCOME;

EID: 33947228882     PISSN: 00223476     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jpeds.2006.12.041     Document Type: Editorial

References (14)

1. Mammel M.C., Green T.P., Johnson D.E., and Thompson T.R. Controlled trial of dexamethasone therapy in infants with bronchopulmonary dysplasia. Lancet 1 (1983) 1356-1358
2. Yeh T.F., Torre J.A., Rastogi A., Anyebuno M.A., and Pildes R.S. Early postnatal dexamethasone therapy in premature infants with severe respiratory distress syndrome: a double-blind, controlled study. J Pediatr 117 (1990) 273-282
3. Walsh MC, Yao Q, Horbar JD, Carpenter JH, Lee SK, Ohlsson A. Changes in the use of postnatal steroids for bronchopulmonary dysplasia in 3 large neonatal networks. Pediatrics 2006. Available at www.pediatrics.org/cgi/doi/10.1542/peds.2006-0359. Accessed February 20, 2007.
4. Yeh T.F., Lin Y.J., Huang C.C., Chen Y.J., Lin C.H., Lin H.C., et al. Early dexamethasone therapy in preterm infants: a follow-up study. Pediatrics 101 (1998) E7
5. O'Shea T.M., Kothadia J.M., Klinepeter K.L., Goldstein D.J., Jackson B.G., Weaver III R.G., et al. Randomized placebo-controlled trial of a 42-day tapering course of dexamethasone to reduce the duration of ventilator dependency in very low birth weight infants: outcome of study participants at 1-year adjusted age. Pediatrics 104 (1999) 15-21
6. Howard E. Reductions in size and total DNA of cerebrum and cerebellum in adult mice after corticosterone treatment in infancy. Exp Neurol 22 (1968) 191-208
7. American Academy of Pediatrics Committee on Fetus and Newborn, and Canadian Paediatric Society Fetus and Newborn Committee. Postnatal corticosteroids to treat or prevent chronic lung disease in preterm infants. Pediatrics 109 (2002) 330-338
8. Doyle L.W., Davis P.G., Morley C.J., McPhee A., Carlin J.B., and DART study investigators. Low-dose dexamethasone facilitates extubation among chronically ventilator-dependent infants: a multicenter, international, randomized, controlled trial. Pediatrics 117 (2006) 75-83
9. Doyle L.W., Halliday H.L., Ehrenkranz R.A., Davis P.G., and Sinclair J.C. Impact of postnatal systemic corticosteroids on mortality and cerebral palsy in preterm infants: effect modification by risk for chronic lung disease. Pediatrics 115 (2005) 655-661
10. Nixon P.A., Washburn L.K., Schechter M.S., and O'Shea T.M. Follow-up study of a randomized controlled trial of postnatal dexamethasone therapy in very low birth weight infants: effects on pulmonary outcomes at 8 to 11 years of age. J Pediatr 150 (2007) 345-350
11. McEwen B.S. The brain is an important target of adrenal steroid actions: a comparison on synthetic and natural steroids. Ann N Y Acad Sci 823 (1997) 201-213
12. Rademaker K.J., Uiterwaal C.S.P.M., Groenendaal F., Uniken Venema M.M.A.T., van Bel F., Beek F.J., et al. Neonatal hydrocortisone treatment: neurodevelopmental outcome and MRI at school age in preterm born children. J Pediatr 150 (2007) 351-357
13. Watterberg K.L., Shaffer M.L., Mishefske M.J., Leach C.L., Mammel M.C., Couser R.J., et al. Growth and Neurodevelopmental Outcomes After Early Low-dose Hydrocortisone Treatment in Extremely Low Birth Weight Infants. Pediatrics (2007) in press
14. Watterberg KL, Shaffer ML, for the PROPHET study group. Cortisol concentrations and apparent serum half-life during hydrocortisone therapy in extremely low birth weight infants. PAS 2005;57:1501. Accessed at www.pas-meeting.org. Accessed February 20, 2007.